SKK
ENZN

Shepherd Kaplan Krochuk’s ENZON PHARMACEUTICALS INC ENZN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ENZN Stock Details ENZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-13,000
Closed -$15K – 679
2013
Q4 		$15K Buy
+13,000
New +$20K ﹤0.01% 529

Other funds holding ENZN

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Shepherd Kaplan Krochuk's ENZN Position: Q1 2014 in Review

Shepherd Kaplan Krochuk sold out of ENZON PHARMACEUTICALS INC (ENZN) in Q1 2014, closing a stake of 13,000 shares — an estimated $15K sold.

Shepherd Kaplan Krochuk first reported a position in ENZN in Q4 2013 and held it in 1 quarter. The position peaked at $15K in Q4 2013. 75 funds tracked by Wall St. Rank hold ENZN as of Q1 2014.

  • Shepherd Kaplan Krochuk reported no remaining ENZON PHARMACEUTICALS INC position as of Q1 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 13,000 ENZON PHARMACEUTICALS INC shares in Q1 2014, an estimated $15K.
  • Shepherd Kaplan Krochuk first reported a position in ENZON PHARMACEUTICALS INC in Q4 2013 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's ENZON PHARMACEUTICALS INC position peaked at $15K in Q4 2013.
  • 75 funds tracked by Wall St. Rank held ENZON PHARMACEUTICALS INC as of Q1 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2014, filed 15 May 2014.